Tower Trust & Investment Company’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$457K Sell
5,311
-1,186
-18% -$104K 0.28% 73
2026
Q1
$587K Sell
6,497
-169
-3% -$15.5K 0.39% 66
2025
Q4
$599K Sell
6,666
-787
-11% -$74.6K 0.38% 68
2025
Q3
$734K Buy
7,453
+77
+1% +$7.63K 0.49% 54
2025
Q2
$673K Sell
7,376
-79
-1% -$7.64K 0.48% 58
2025
Q1
$768K Buy
+7,455
New +$798K 0.62% 44

Other funds holding ZBH

Tower Trust & Investment Company's ZBH Position: Q2 2026 in Review

Tower Trust & Investment Company reduced its Zimmer Biomet (ZBH) stake by 18% in Q2 2026, selling an estimated $104K and leaving 5,311 shares worth $457K. The position accounts for 0.28% of the portfolio, ranked #73.

Tower Trust & Investment Company first reported a position in ZBH in Q1 2025 and has held it in 6 quarters since. The position peaked at $768K in Q1 2025. 348 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Tower Trust & Investment Company held 5,311 shares of Zimmer Biomet worth $457K as of Q2 2026.
  • Tower Trust & Investment Company sold 1,186 Zimmer Biomet shares in Q2 2026, an estimated $104K.
  • Zimmer Biomet made up 0.28% of Tower Trust & Investment Company's portfolio in Q2 2026, its #73 holding.
  • Tower Trust & Investment Company first reported a position in Zimmer Biomet in Q1 2025 and has held it in 6 quarters since.
  • Tower Trust & Investment Company's Zimmer Biomet position peaked at $768K in Q1 2025.
  • 348 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Tower Trust & Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.